Krystal Biotech, Inc. (KRYS)
NASDAQ·Healthcare·Biotechnology
$259.48
-3.64%
Mkt Cap $8.07B
Analyst Ratings
Buy
12
Hold
1
Sell
0
Price Target (12 analysts)
$311.00
Range $224.00 – $371.00
Implied Upside
+19.9%
Consensus $311.00 vs current $259.48
NASDAQ·Healthcare·Biotechnology
$259.48
-3.64%
Mkt Cap $8.07B
Buy
12
Hold
1
Sell
0
Price Target (12 analysts)
$311.00
Range $224.00 – $371.00
+19.9%
Consensus $311.00 vs current $259.48